CompletedPhase 3NCT05163561

Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Serum Institute of India Pvt. Ltd.
Principal Investigator
K Zaman, MD
International Centre for Diarrhoeal Disease Research, Bangladesh
Intervention
SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A(biological)
Enrollment
1072 enrolled
Eligibility
All sexes
Timeline
2022 – 2023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05163561 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials